INS and gestational diabetes: Importantly, direct comparisons between GDM-I and GDM-D revealed that GDM-I placentas exhibited significantly higher levels of active mTOR than GDM-D placentas (p < 0.05), suggesting insulin treatment may amplify mTOR signaling more than dietary management.